![VXJ VXJ](https://data.pdbj.org/pdbjplus/data/cc/svg/VXJ.svg) | VXJ | Name: | N-(3-chloro-4-fluorophenyl)-3-phenyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide | Formula: | C19 H16 Cl F N4 O | SMILES: | c1c(c(cc(c1)NC(=O)N2Cc3c(CC2)nnc3c4ccccc4)Cl)F | InChi: | InChI=1S/C19H16ClFN4O/c20-15-10-13(6-7-16(15)21)22-19(26)25-9-8-17-14(11-25)18(24-23-17)12-4-2-1-3-5-12/h1-7,10H,8-9,11H2,(H,22,26)(H,23,24) | Definition date: | 2020-09-18 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | N-(3-chloro-4-fluorophenyl)-3-phenyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide |
|
![S7N S7N](https://data.pdbj.org/pdbjplus/data/cc/svg/S7N.svg) | S7N | Name: | (phenylmethyl) ~{N}-[(2~{R})-3-methyl-1-[[(2~{S})-1-[[(3~{S})-1-methylsulfanyl-4-oxidanylidene-pentan-3-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-butan-2-yl]carbamate | Formula: | C22 H33 N3 O5 S | SMILES: | CSCC[CH](NC(=O)[CH](C)NC(=O)[CH](NC(=O)OCc1ccccc1)C(C)C)C(C)=O | InChi: | InChI=1S/C22H33N3O5S/c1-14(2)19(25-22(29)30-13-17-9-7-6-8-10-17)21(28)23-15(3)20(27)24-18(16(4)26)11-12-31-5/h6-10,14-15,18-19H,11-13H2,1-5H3,(H,23,28)(H,24,27)(H,25,29)/t15-,18-,19+/m0/s1 | Synonyms: | Z-VAM-FMK | Definition date: | 2020-11-10 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | (phenylmethyl) ~{N}-[(2~{R})-3-methyl-1-[[(2~{S})-1-[[(3~{S})-1-methylsulfanyl-4-oxidanylidene-pentan-3-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-butan-2-yl]carbamate |
|
![S7Q S7Q](https://data.pdbj.org/pdbjplus/data/cc/svg/S7Q.svg) | S7Q | Name: | (phenylmethyl) ~{N}-[(2~{S})-3-methyl-1-[[(2~{R})-1-[[(3~{R})-1-methylsulfanyl-4-oxidanylidene-pentan-3-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-butan-2-yl]carbamate | Formula: | C22 H33 N3 O5 S | SMILES: | CSCC[CH](NC(=O)[CH](C)NC(=O)[CH](NC(=O)OCc1ccccc1)C(C)C)C(C)=O | InChi: | InChI=1S/C22H33N3O5S/c1-14(2)19(25-22(29)30-13-17-9-7-6-8-10-17)21(28)23-15(3)20(27)24-18(16(4)26)11-12-31-5/h6-10,14-15,18-19H,11-13H2,1-5H3,(H,23,28)(H,24,27)(H,25,29)/t15-,18-,19+/m1/s1 | Synonyms: | zVAM.fmk | Definition date: | 2020-11-10 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | (phenylmethyl) ~{N}-[(2~{S})-3-methyl-1-[[(2~{R})-1-[[(3~{R})-1-methylsulfanyl-4-oxidanylidene-pentan-3-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-butan-2-yl]carbamate |
|
![ZHM ZHM](https://data.pdbj.org/pdbjplus/data/cc/svg/ZHM.svg) | ZHM | Name: | 2-(2,5-dibromophenoxy)-6-[4-methyl-1-(piperidin-4-yl)-1H-1,2,3-triazol-5-yl]pyridine | Formula: | C19 H19 Br2 N5 O | SMILES: | Brc1cc(Oc2cccc(n2)c2c(C)nnn2C2CCNCC2)c(Br)cc1 | InChi: | InChI=1S/C19H19Br2N5O/c1-12-19(26(25-24-12)14-7-9-22-10-8-14)16-3-2-4-18(23-16)27-17-11-13(20)5-6-15(17)21/h2-6,11,14,22H,7-10H2,1H3 | Definition date: | 2021-04-29 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2-(2,5-dibromophenoxy)-6-[4-methyl-1-(piperidin-4-yl)-1H-1,2,3-triazol-5-yl]pyridine |
|
![ZHS ZHS](https://data.pdbj.org/pdbjplus/data/cc/svg/ZHS.svg) | ZHS | Name: | 2-(4-{5-[6-(3,5-dimethylphenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine | Formula: | C25 H34 N6 O | SMILES: | Cc1cc(cc(C)c1)Oc1cccc(n1)c1c(C)nnn1C1CCN(CCN(C)C)CC1 | InChi: | InChI=1S/C25H34N6O/c1-18-15-19(2)17-22(16-18)32-24-8-6-7-23(26-24)25-20(3)27-28-31(25)21-9-11-30(12-10-21)14-13-29(4)5/h6-8,15-17,21H,9-14H2,1-5H3 | Definition date: | 2021-04-29 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2-(4-{5-[6-(3,5-dimethylphenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine |
|
![ZHV ZHV](https://data.pdbj.org/pdbjplus/data/cc/svg/ZHV.svg) | ZHV | Name: | 2-(4-{5-[6-(2,5-dibromophenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine | Formula: | C23 H28 Br2 N6 O | SMILES: | Brc1cc(Oc2cccc(n2)c2c(C)nnn2C2CCN(CCN(C)C)CC2)c(Br)cc1 | InChi: | InChI=1S/C23H28Br2N6O/c1-16-23(31(28-27-16)18-9-11-30(12-10-18)14-13-29(2)3)20-5-4-6-22(26-20)32-21-15-17(24)7-8-19(21)25/h4-8,15,18H,9-14H2,1-3H3 | Definition date: | 2021-04-29 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2-(4-{5-[6-(2,5-dibromophenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine |
|
![YFP YFP](https://data.pdbj.org/pdbjplus/data/cc/svg/YFP.svg) | YFP | Name: | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol | Formula: | C40 H77 O10 P | SMILES: | O=C(OC(COP(O)(=O)OCC(O)CO)COC(=O)CCCCCCCCCCCCCCC)CCCCCCCC=CCCCCCCCC | InChi: | InChI=1S/C40H77O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,37-38,41-42H,3-16,19-36H2,1-2H3,(H,45,46)/t37?,38-/m1/s1 | Definition date: | 2021-02-25 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | (19R,22R)-22,25,26-trihydroxy-16,22-dioxo-17,21,23-trioxa-22lambda~5~-phosphahexacosan-19-yl octadec-9-enoate |
|
![YFS YFS](https://data.pdbj.org/pdbjplus/data/cc/svg/YFS.svg) | YFS | Name: | N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-D-leucinamide | Formula: | C16 H21 N3 O3 | SMILES: | c1(ccc(cc1OC)NC(C(N)CC(C)C)=O)c2ocnc2 | InChi: | InChI=1S/C16H21N3O3/c1-10(2)6-13(17)16(20)19-11-4-5-12(14(7-11)21-3)15-8-18-9-22-15/h4-5,7-10,13H,6,17H2,1-3H3,(H,19,20)/t13-/m1/s1 | Definition date: | 2021-02-26 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-D-leucinamide |
|
![YFV YFV](https://data.pdbj.org/pdbjplus/data/cc/svg/YFV.svg) | YFV | Name: | 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine | Formula: | C23 H28 N8 S | SMILES: | c3(c1n(ccc1CN2CCC(CC2)N)ncn3)Nc4cccc(c4)c5sc(C(C)C)nn5 | InChi: | InChI=1S/C23H28N8S/c1-15(2)22-28-29-23(32-22)16-4-3-5-19(12-16)27-21-20-17(6-11-31(20)26-14-25-21)13-30-9-7-18(24)8-10-30/h3-6,11-12,14-15,18H,7-10,13,24H2,1-2H3,(H,25,26,27) | Definition date: | 2021-02-26 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine |
|
![YFY YFY](https://data.pdbj.org/pdbjplus/data/cc/svg/YFY.svg) | YFY | Name: | (2R,3R)-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide | Formula: | C19 H25 N3 O3 | SMILES: | COc2cc(ccc2c1cnco1)NC(=O)C3C(C(C)C)CCCN3 | InChi: | InChI=1S/C19H25N3O3/c1-12(2)14-5-4-8-21-18(14)19(23)22-13-6-7-15(16(9-13)24-3)17-10-20-11-25-17/h6-7,9-12,14,18,21H,4-5,8H2,1-3H3,(H,22,23)/t14-,18-/m1/s1 | Definition date: | 2021-02-26 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | (2R,3R)-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide |
|
![ZKM ZKM](https://data.pdbj.org/pdbjplus/data/cc/svg/ZKM.svg) | ZKM | Name: | N-[(1S,2R,3E)-2-hydroxy-1-{[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl}heptadec-3-en-1-yl]-hexadecanamide | Formula: | C40 H77 N O11 S | SMILES: | CCCCCCCCCCCCCC=CC(O)C(COC1OC(CO)C(O)C(OS(=O)(=O)O)C1O)NC(=O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C40H77NO11S/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(43)33(32-50-40-38(46)39(52-53(47,48)49)37(45)35(31-42)51-40)41-36(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,33-35,37-40,42-43,45-46H,3-26,28,30-32H2,1-2H3,(H,41,44)(H,47,48,49)/b29-27+/t33-,34+,35+,37-,38+,39-,40+/m0/s1 | Definition date: | 2021-04-30 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | N-{(2S,3R,4E)-3-hydroxy-1-[(3-O-sulfo-beta-D-galactopyranosyl)oxy]octadec-4-en-2-yl}hexadecanamide |
|
![V8A V8A](https://data.pdbj.org/pdbjplus/data/cc/svg/V8A.svg) | V8A | Name: | 2,7-bis[3-(morpholin-4-yl)propyl]-4,9-bis{[3-(morpholin-4-yl)propyl]amino}benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone | Formula: | C42 H60 N8 O8 | SMILES: | C(CCN1CCOCC1)N2C(=O)c7c6c(C2=O)cc(NCCCN3CCOCC3)c5C(=O)N(CCCN4CCOCC4)C(c(c56)cc7NCCCN8CCOCC8)=O | InChi: | InChI=1S/C42H60N8O8/c51-39-31-29-33(43-5-1-7-45-13-21-55-22-14-45)37-35-32(40(52)49(41(37)53)11-3-9-47-17-25-57-26-18-47)30-34(44-6-2-8-46-15-23-56-24-16-46)38(36(31)35)42(54)50(39)12-4-10-48-19-27-58-28-20-48/h29-30,43-44H,1-28H2 | Definition date: | 2020-07-14 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2,7-bis[3-(morpholin-4-yl)propyl]-4,9-bis{[3-(morpholin-4-yl)propyl]amino}benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone |
|
![V8B V8B](https://data.pdbj.org/pdbjplus/data/cc/svg/V8B.svg) | V8B | Name: | 6-methyl-3-[4-(2-oxidanylpropan-2-yl)phenyl]-4~{H}-pyrrolo[1,2-a]pyrazin-1-one | Formula: | C17 H18 N2 O2 | SMILES: | Cc1ccc2n1CC(=NC2=O)c3ccc(cc3)C(C)(C)O | InChi: | InChI=1S/C17H18N2O2/c1-11-4-9-15-16(20)18-14(10-19(11)15)12-5-7-13(8-6-12)17(2,3)21/h4-9,21H,10H2,1-3H3 | Definition date: | 2021-04-28 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 6-methyl-3-[4-(2-oxidanylpropan-2-yl)phenyl]-4~{H}-pyrrolo[1,2-a]pyrazin-1-one |
|
![G5X G5X](https://data.pdbj.org/pdbjplus/data/cc/svg/G5X.svg) | G5X | Name: | 1-(2-azanylpyrimidin-4-yl)-6-[2-(1-oxidanylcyclohexyl)ethynyl]indole-3-carboxamide | Formula: | C21 H21 N5 O2 | SMILES: | NC(=O)c1cn(c2ccnc(N)n2)c3cc(ccc13)C#CC4(O)CCCCC4 | InChi: | InChI=1S/C21H21N5O2/c22-19(27)16-13-26(18-7-11-24-20(23)25-18)17-12-14(4-5-15(16)17)6-10-21(28)8-2-1-3-9-21/h4-5,7,11-13,28H,1-3,8-9H2,(H2,22,27)(H2,23,24,25) | Definition date: | 2020-07-30 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 1-(2-azanylpyrimidin-4-yl)-6-[2-(1-oxidanylcyclohexyl)ethynyl]indole-3-carboxamide |
|
![TEQ TEQ](https://data.pdbj.org/pdbjplus/data/cc/svg/TEQ.svg) | TEQ | Name: | 5-[(5S,7R)-3-fluoranyl-7-(2-methylpyridin-3-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-5-yl]quinolin-2-amine | Formula: | C21 H19 F N6 | SMILES: | Cc1ncccc1[CH]2C[CH](Nc3n2ncc3F)c4cccc5nc(N)ccc45 | InChi: | InChI=1S/C21H19FN6/c1-12-13(5-3-9-24-12)19-10-18(27-21-16(22)11-25-28(19)21)14-4-2-6-17-15(14)7-8-20(23)26-17/h2-9,11,18-19,27H,10H2,1H3,(H2,23,26)/t18-,19+/m0/s1 | Synonyms: | 5-[(5~{S},7~{R})-3-fluoranyl-7-(2-methylpyridin-3-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-5-yl]quinolin-2-amine | Definition date: | 2020-12-21 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 5-[(5~{S},7~{R})-3-fluoranyl-7-(2-methylpyridin-3-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-5-yl]quinolin-2-amine |
|
![GOU GOU](https://data.pdbj.org/pdbjplus/data/cc/svg/GOU.svg) | GOU | Name: | 6-chloranyl-9-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]purin-2-amine | Formula: | C12 H13 Cl N6 O | SMILES: | CC(C)c1cc(Cn2cnc3c(Cl)nc(N)nc23)on1 | InChi: | InChI=1S/C12H13ClN6O/c1-6(2)8-3-7(20-18-8)4-19-5-15-9-10(13)16-12(14)17-11(9)19/h3,5-6H,4H2,1-2H3,(H2,14,16,17) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 6-chloranyl-9-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]purin-2-amine |
|
![GQ0 GQ0](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ0.svg) | GQ0 | Name: | 9-[(3-tert-butyl-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine | Formula: | C13 H15 Cl N6 O | SMILES: | CC(C)(C)c1cc(Cn2cnc3c(Cl)nc(N)nc23)on1 | InChi: | InChI=1S/C13H15ClN6O/c1-13(2,3)8-4-7(21-19-8)5-20-6-16-9-10(14)17-12(15)18-11(9)20/h4,6H,5H2,1-3H3,(H2,15,17,18) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 9-[(3-~{tert}-butyl-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine |
|
![GQ3 GQ3](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ3.svg) | GQ3 | Name: | 9-[(3-tert-butyl-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine | Formula: | C13 H17 Cl N6 O | SMILES: | CC(C)(C)C1=NO[CH](Cn2cnc3c(Cl)nc(N)nc23)C1 | InChi: | InChI=1S/C13H17ClN6O/c1-13(2,3)8-4-7(21-19-8)5-20-6-16-9-10(14)17-12(15)18-11(9)20/h6-7H,4-5H2,1-3H3,(H2,15,17,18)/t7-/m1/s1 | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 9-[(3-~{tert}-butyl-4,5-dihydro-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine |
|
![GQ6 GQ6](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ6.svg) | GQ6 | Name: | 6-chloranyl-9-[(4-methylphenyl)methyl]purin-2-amine | Formula: | C13 H12 Cl N5 | SMILES: | Cc1ccc(Cn2cnc3c(Cl)nc(N)nc23)cc1 | InChi: | InChI=1S/C13H12ClN5/c1-8-2-4-9(5-3-8)6-19-7-16-10-11(14)17-13(15)18-12(10)19/h2-5,7H,6H2,1H3,(H2,15,17,18) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 6-chloranyl-9-[(4-methylphenyl)methyl]purin-2-amine |
|
![GQ9 GQ9](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ9.svg) | GQ9 | Name: | 6-chloranyl-9-[(2-phenyl-1,3-oxazol-5-yl)methyl]purin-2-amine | Formula: | C15 H11 Cl N6 O | SMILES: | Nc1nc(Cl)c2ncn(Cc3oc(nc3)c4ccccc4)c2n1 | InChi: | InChI=1S/C15H11ClN6O/c16-12-11-13(21-15(17)20-12)22(8-19-11)7-10-6-18-14(23-10)9-4-2-1-3-5-9/h1-6,8H,7H2,(H2,17,20,21) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 6-chloranyl-9-[(2-phenyl-1,3-oxazol-5-yl)methyl]purin-2-amine |
|
![1AI 1AI](https://data.pdbj.org/pdbjplus/data/cc/svg/1AI.svg) | 1AI | Name: | ~{N}-[(2-methylphenyl)methyl]-3-[(2-methylphenyl)methylamino]pyrazine-2-carboxamide | Formula: | C21 H22 N4 O | SMILES: | Cc1ccccc1CNC(=O)c2nccnc2NCc3ccccc3C | InChi: | InChI=1S/C21H22N4O/c1-15-7-3-5-9-17(15)13-24-20-19(22-11-12-23-20)21(26)25-14-18-10-6-4-8-16(18)2/h3-12H,13-14H2,1-2H3,(H,23,24)(H,25,26) | Definition date: | 2021-06-09 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | ~{N}-[(2-methylphenyl)methyl]-3-[(2-methylphenyl)methylamino]pyrazine-2-carboxamide |
|
![0W4 0W4](https://data.pdbj.org/pdbjplus/data/cc/svg/0W4.svg) | 0W4 | Name: | ~{N}-[(2-chlorophenyl)methyl]-3-[(2-chlorophenyl)methylamino]pyrazine-2-carboxamide | Formula: | C19 H16 Cl2 N4 O | SMILES: | Clc1ccccc1CNC(=O)c2nccnc2NCc3ccccc3Cl | InChi: | InChI=1S/C19H16Cl2N4O/c20-15-7-3-1-5-13(15)11-24-18-17(22-9-10-23-18)19(26)25-12-14-6-2-4-8-16(14)21/h1-10H,11-12H2,(H,23,24)(H,25,26) | Definition date: | 2021-06-09 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | ~{N}-[(2-chlorophenyl)methyl]-3-[(2-chlorophenyl)methylamino]pyrazine-2-carboxamide |
|
![0X7 0X7](https://data.pdbj.org/pdbjplus/data/cc/svg/0X7.svg) | 0X7 | Name: | 3-[(2-methylphenyl)methylamino]pyrazine-2-carboxamide | Formula: | C13 H14 N4 O | SMILES: | Cc1ccccc1CNc2nccnc2C(N)=O | InChi: | InChI=1S/C13H14N4O/c1-9-4-2-3-5-10(9)8-17-13-11(12(14)18)15-6-7-16-13/h2-7H,8H2,1H3,(H2,14,18)(H,16,17) | Definition date: | 2021-06-09 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 3-[(2-methylphenyl)methylamino]pyrazine-2-carboxamide |
|
![0YI 0YI](https://data.pdbj.org/pdbjplus/data/cc/svg/0YI.svg) | 0YI | Name: | 3-[(2-chlorophenyl)methylamino]pyrazine-2-carboxamide | Formula: | C12 H11 Cl N4 O | SMILES: | NC(=O)c1nccnc1NCc2ccccc2Cl | InChi: | InChI=1S/C12H11ClN4O/c13-9-4-2-1-3-8(9)7-17-12-10(11(14)18)15-5-6-16-12/h1-6H,7H2,(H2,14,18)(H,16,17) | Definition date: | 2021-06-09 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 3-[(2-chlorophenyl)methylamino]pyrazine-2-carboxamide |
|
![0YK 0YK](https://data.pdbj.org/pdbjplus/data/cc/svg/0YK.svg) | 0YK | Name: | 7-(4-cyclohexyloxyphenyl)-9-methyl-4$l^{6}-thia-1$l^{4},5,8-triazabicyclo[4.4.0]deca-1(10),6,8-triene 4,4-dioxide | Formula: | C19 H23 N3 O3 S | SMILES: | CC1=CN2CC[S](=O)(=O)N=C2C(=N1)c3ccc(OC4CCCCC4)cc3 | InChi: | InChI=1S/C19H23N3O3S/c1-14-13-22-11-12-26(23,24)21-19(22)18(20-14)15-7-9-17(10-8-15)25-16-5-3-2-4-6-16/h7-10,13,16H,2-6,11-12H2,1H3 | Definition date: | 2021-06-17 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 9-(4-cyclohexyloxyphenyl)-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide |
|